Silo Pharma, Inc. - SILO

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$408K
QoQ value delta ($000)
-$658K (-61.73%)
Implied price effect (QoQ)
-51.09%
Shares
Total shares
1,213,640
QoQ shares delta
-337,382 (-21.75%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (SILO)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
AdvisorShares Investments LLC 203 599,507 0.03%
DRW Securities, LLC 113 333,733 0.0%
GEODE CAPITAL MANAGEMENT, LLC 31 92,905 0.0%
XTX Topco Ltd 19 56,899 0.0%
JANE STREET GROUP, LLC 11 34,373 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 10 29,577 0.0%
VANGUARD GROUP INC 8 24,321 0.0%
Virtu Financial LLC 6 18,418 0.0%
STATE STREET CORP 4 12,500 0.0%
UBS Group AG 2 6,043 0.0%
CITIGROUP INC 1 3,451 0.0%
BANK OF AMERICA CORP /DE/ 0 114 0.0%
WELLS FARGO & COMPANY/MN 0 10 0.0%
Tower Research Capital LLC (TRC) 0 1,695 0.0%
Westside Investment Management, Inc. 0 94 0.0%